Depression and Anxiety Trial, Recruiting NCT06972368 Sponsor: Ciusss de L'Est de l'Île de Montréal Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06972368
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65
  • People who have been diagnosed with Borderline Personality Disorder (BPD) according to standard diagnostic guidelines
  • People who are currently experiencing a moderate level of depression, confirmed by a specific depression rating scale score at two points in the study process
  • People who are able to understand and agree to take part in the study
  • People who speak French or English
  • People who have a prescribing doctor or mental health professional currently responsible for their care
  • People whose current medications and any talking therapies have been stable and unchanged
  • People who have access to the internet and own a smartphone
  • People who are able to learn and independently operate a home-use brain stimulation device (called a tDCS device)
  • People who are able to collect and return the brain stimulation device from and to the trial site

Who may not be able to join:

  • People with a history of epilepsy
  • People who have a medical reason why a tDCS brain stimulation device cannot be used on them (confirm with trial site)
  • People who have previously had brain or blood vessel surgery
  • People with skin or scalp conditions that would affect where the tDCS device's electrodes are placed
  • People with a history of bipolar disorder
  • People whose personal or medical situation would make it difficult to use the brain stimulation device independently at home
  • People who are currently pregnant
  • People who are currently receiving any other type of brain stimulation treatment
  • People who are currently taking benzodiazepine medications (a type of sedative or anti-anxiety medication)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-251-4000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ciusss de L'Est de l'Île de Montréal
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility and Acceptability of Home-Based tDCS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov